Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice

References

• Amr AF, Mohamed AM, Wafaey G. 2008. Protective effect of carnosine against cisplatin-induced nephrotoxicity in mice. Environ Toxicol Pharmacol. 25:292–297.
   PubMed Web of Science ®Google Scholar
• An Y, Xin H, Yan W, Zhou X. 2009. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Exp Toxicol Pathol. 63:215–219.
   Web of Science ®Google Scholar
• Arany I, Safirstein RL. 2003. Cisplatin nephrotoxicity. Semin Nephrol. 5:460–464.
   Google Scholar
• Bartels H, Bohmer M, Heierli C. 1972. Serum creatinine determination without protein precipitation. Clin Chim Acta. 37:193–197.
   PubMed Web of Science ®Google Scholar
• Bataille R, Jourdan M, Zhang XG, Klein B. 1989. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest. 84:2008–2011.
   PubMed Web of Science ®Google Scholar
• Bauer AK, Dwyer-Nield LD, Malkinson AM. 2000. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 21:543–550.
   PubMed Web of Science ®Google Scholar
• Beutler E, Durgun O, Kelly BM. 1963. Improved method for the determination of blood glutathione. J Lab Clin Med. 51:882–888.
   Google Scholar
• Burger H, Loose WJ, Eechoute K, Verweij J, Mathijssen RHJ, Wiemer EAC. 2011. Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resist Updat. 14:22–34.
   PubMed Web of Science ®Google Scholar
• Chan DW, Perlstein MT. 1987. Immunoassay: a practical guide. Orlando, USA: Academic Press.
   Google Scholar
• Chirino YI, Sánchez-González DJ, Martínez-Martínez CM, Cruz C, Pedraza-Chaverri J. 2008. Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology. 245:18–23.
   PubMed Web of Science ®Google Scholar
• Choi EJ, Kim GH. 2009 . Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 Cells. J Clin Biochem Nutr. 44:260–265.
   PubMed Web of Science ®Google Scholar
• Cohen GM. 1997. Caspases: the executioners of apoptosis (review). Biochem J. 326:1–16.
   PubMed Web of Science ®Google Scholar
• Davis CA, Nick HS, Agarwal A. 2001. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. Clin J Am Soc Nephrol. 12:2683–2690.
   Google Scholar
• Ding Y, Zhang ZF, Dai XQ, Yong L. 2012 . Myricetin protects against cytokine-induced cell death in RIN-m5f β cells . J Med Food. 15:733–740.
   PubMed Web of Science ®Google Scholar
• Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Leo BA, Van De Putte LBA, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J. 12:1063–1073.
   PubMed Web of Science ®Google Scholar
• Durak I, Ozbek H, Karaayvaz M, Ozturk HS. 2002. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol. 25:1–8.
   PubMed Web of Science ®Google Scholar
• Fawcett JK, Scott JE. 1960. A rapid and precise method for the determination of urea. J Clin Pathol. 13:156–159.
   PubMed Web of Science ®Google Scholar
• Frezza M, Hindo S, Chen D, Davenport A, Schmitt S, Tomco D, Dou QP. 2013. Novel metals and metal complexes as platforms for cancer therapy. Curr Pharm Des. 16:1813–1825.
   Google Scholar
• Funakoshi-Tago M, Nakamura K, Tago K, Mashino T, Kasahara T. 2011. Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin. Int Immunopharmacol. 11:1150–1159.
   PubMed Web of Science ®Google Scholar
• Góth L. 1991. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 196:143–151.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Venegas G, Alonso-Luna O, Ventura-Arroyo JA, Hernández-Bermúdez C. 2013. Myricetin suppresses lipoteichoic acid-induced interleukin-1β and cyclooxygenase-2 expression in human gingival fibroblasts. Microbiol Immunol. 57:849–856.
   PubMed Web of Science ®Google Scholar
• Humanes B, Lazaro A, Camano S, Moreno-Gordaliza E, Lazaro JA, Blanco-Codesido M. 2012. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int. 82:652–663.
   PubMed Web of Science ®Google Scholar
• Kaushal GP, Kaushal V, Hong X. 2001. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 60:1726–1736.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Taniuchi S, Okahara S, Nakamura M, Gemba M. 2005. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol Pharm Bull. 28:1385–1388.
   PubMed Web of Science ®Google Scholar
• Lee KH, Choi EM. 2008 . Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-d-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells. Eur J Pharmacol. 591:1–6.
   PubMed Web of Science ®Google Scholar
• Lee YS, Choi EM. 2010. Myricetin inhibits IL-1beta-induced inflammatory mediators in SW982 human synovial sarcoma cells. Int Immunopharmacol. 10:812–814.
   PubMed Web of Science ®Google Scholar
• Miean KH, Mohamed S. 2001. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 49:3106–3112.
   PubMed Web of Science ®Google Scholar
• Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. 2010. Mechanisms of cisplatin nephrotoxicity. Toxins. 2:2490–2518.
   PubMed Web of Science ®Google Scholar
• Min L, Thing-Fong T, Shorong-Shii L, Ting-Wei L. 2007. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats. Life Sci. 81:1479–1488.
   PubMed Web of Science ®Google Scholar
• Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR. 2002 . Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res. 36:1199–1208.
   PubMed Web of Science ®Google Scholar
• Ozcan F, Ozmen A, Akkaya B, Aliciguzel Y, Aslan M. 2012. Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clin Exp Med. 12:265–272.
   PubMed Web of Science ®Google Scholar
• Pabla N, Dong Z. 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73:994–1007.
   PubMed Web of Science ®Google Scholar
• Pan H, Chen J, Shen K, Wang X, Wang P, Fu G, Meng H, Wang Y, Jin B. 2015. Mitochondrial modulation by epigallocatechin 3-gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-κB in mice. PLoS One. 10:1371.
   Web of Science ®Google Scholar
• Pan H, Mukhopadhyay P, Rajesh M, Patel V, Mukhopadhyay B, Gao B, Haskó G, Pacher P. 2009. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther. 328:708–714.
   PubMed Web of Science ®Google Scholar
• Patel D, Shukla S, Gupta S. 2007. Apigenin and cancer chemoprevention progress, potential and promise. Int J Oncology. 30:233–245.
   PubMed Web of Science ®Google Scholar
• Peterson LA, Cummings ME. 2005. Identification of a cis-2-butene-1, 4-dial-derived glutathione conjugate in the urine of furan-treated rats. Drug Metab Dispos. 33:1453–1458.
   PubMed Web of Science ®Google Scholar
• Ramesh G, Reeves WB. 2004. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. Kidney Int. 65:490–499.
   PubMed Web of Science ®Google Scholar
• Rodrigues MAC, Rodrigues JL, Martins NM, Barbosa F, Curti C, Santos NAG. 2011. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem Biol Interact. 189:45–51.
   PubMed Web of Science ®Google Scholar
• Rong S, Zhao Y, Bao W, Xiao X, Wang D. 2012. Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine. 19:545–550.
   PubMed Web of Science ®Google Scholar
• Sahu SC, Gray GC. 1996. Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett. 104:193–196.
   PubMed Web of Science ®Google Scholar
• Sahu BD, Reddy KKR, Putcha UK, Kuncha M, Naidu VGM, Sistla R. 2011. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Food Chem Toxicol. 49:3090–3097.
   PubMed Web of Science ®Google Scholar
• Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H. 2008. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: involvement of direct inhibition of caspase-3. J Neurosci Res. 86:1836–1845.
   PubMed Web of Science ®Google Scholar
• Silvan S, Manoharan S. 2013 . Apigenin prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Arch Oral Biol. 58:94–101.
   PubMed Web of Science ®Google Scholar
• Singh JP, Selvendiran K, Banu SM, Padmavathi R, Sakthisekaran D. 2004. Protective role of apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine. 11:309–314.
   PubMed Web of Science ®Google Scholar
• Tayem Y, Johnson TR, Mann BE, Green CJ, Motterlini R. 2006. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide releasing molecule. Am J Renal Physiol. 290:789–794.
   Web of Science ®Google Scholar
• Valdameri G, Trombetta-Lima M, Worfel PR, Amanda RA, Pires ARA, Glaucia R, Martinez GR, Noleto GR, Cadena SMSC, Mari C, et al. 2011. Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells. Chem Biol Interact. 193:180–189.
   PubMed Web of Science ®Google Scholar
• Van Weemen BK, Schuurs AH. 1971. Immunoassay using antigen-enzyme conjugates. FEBS Lett. 15:232–236.
   PubMed Web of Science ®Google Scholar
• Vickers AE, Rose K, Fisher R. 2004. Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol. 32:577–590.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu YT, Xiao L, Zhu L, Wang Q, Yan T. 2014. Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway. Inflammation. 37:2085–2090.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang XY, Xue J, Gu ZL, Xie ML. 2013. Protective effect of apigenin on mouse acute liver injury induced by acetaminophen is associated with increment of hepatic glutathione reductase activity. Food Funct. 4:939–943.
   PubMed Web of Science ®Google Scholar
• Yao X, Panichpisal K, Kurtzman N, Nugent K. 2007. Cisplatin nephrotoxicity: a review. Am J Med Sci. 334:115–124.
   PubMed Web of Science ®Google Scholar
• Yao FF, Wei HE. 2011. Effects of quercetin and apigenin on serum uric acid and antioxidant capacity in hyperuricemic rats. Food Sci. 32:287–290.
   Google Scholar